Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1988-11-21
pubmed:abstractText
We have studied synergism between adrenaline (epinephrine) and low concentrations of thrombin in gel-filtered human platelets prelabelled with [32P]Pi. Suspensions of platelets, which did not contain added fibrinogen, were incubated at 37 degrees C to measure changes in the levels of 32P-labelled phosphatidylinositol 4,5-bisphosphate (PIP2), phosphatidylinositol 4-phosphate (PIP) and phosphatidate (PA), aggregation and dense-granule secretion after stimulation. Adrenaline alone (3.5-4.0 microM) did not cause a change in any parameter (phosphoinositide metabolism, aggregation and dense-granule secretion), but markedly enhanced the thrombin-induced responses over a narrow range of thrombin concentrations (0.03-0.08 units/ml). The thrombin-induced hydrolysis of inositol phospholipids by phospholipase C, which was measured as the formation of [32P]PA, was potentiated by adrenaline, as was the increase in the levels of [32P]PIP2 and [32P]PIP. The presence of adrenaline caused a shift to the left for the thrombin-induced changes in the phosphoinositide metabolism, without affecting the maximal levels of 32P-labelled compounds obtained. A similar shift by adrenaline in the dose-response relationship was previously demonstrated for thrombin-induced aggregation and dense-granule secretion. Also, the narrow range of concentrations of thrombin over which adrenaline potentiates thrombin-induced platelet responses is the same for changes in phosphoinositide metabolism and physiological responses (aggregation and dense-granule secretion). Our observations clearly indicate that adrenaline directly or indirectly influences thrombin-induced changes in phosphoinositide metabolism.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-14159460, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-14175, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-2418346, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-2994234, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-2997148, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-3001964, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-3009439, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-3013858, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-3013859, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-3018010, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-3022313, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-3024170, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-3036103, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-3081507, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-3110213, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-3115820, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-3298961, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-34106, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-3490977, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-3593215, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-3609294, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-3617010, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-4089798, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-6059520, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-6089753, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-6116620, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-6253495, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-6300061, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-6307295, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-6318378, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-6326566, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-6329175, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-6429141, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-6769176, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845924-6789496
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
253
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
581-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Synergism between thrombin and adrenaline (epinephrine) in human platelets. Marked potentiation of inositol phospholipid metabolism.
pubmed:affiliation
Department of Biochemistry, University of Bergen, Norway.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't